Latest news
October 30, 2025
Debiopharm Forges AI-Powered Alliance with NetTargets to Pioneer Dual-Payload ADCs Against Drug-Resistant Cancers
April 22, 2025
Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in…
September 21, 2023
Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers